Antigen-Conjugated Silica Solid Sphere as Nanovaccine for Cancer Immunotherapy

BACKGROUND: Nanocarriers could deliver significantly higher amounts of antigen to antigen-presenting cells (APCs), which have great potential to stimulate humoral and cellular response in cancer immunotherapy. Thereafter, silica solid nanosphere (SiO(2)) was prepared, and a model antigen (ovalbumin,...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Ying, Gao, Jing, Pei, Mengyue, Wang, Xiaoli, Zhang, Chuangnian, Du, Yingjie, Jiang, Yanjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184137/
https://www.ncbi.nlm.nih.gov/pubmed/32368049
http://dx.doi.org/10.2147/IJN.S242463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184137/
https://www.ncbi.nlm.nih.gov/pubmed/32368049
http://dx.doi.org/10.2147/IJN.S242463

Ejemplares similares